Loading…
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine
Dodick, David W, Doty, Erin G, Aurora, Sheena K, Ruff, Dustin D, Stauffer, Virginia L, Jedynak, Jakub, Dong, Yan, Pearlman, Eric M
Published in Cephalalgia (01.03.2021)
Published in Cephalalgia (01.03.2021)
Get full text
Journal Article
Loading…
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)
Brandes, Jan Lewis, Klise, Suzanne, Krege, John H, Case, Michael, Khanna, Rashna, Vasudeva, Raghavendra, Raskin, Joel, Pearlman, Eric M, Kudrow, David
Published in Cephalalgia (01.10.2019)
Published in Cephalalgia (01.10.2019)
Get full text
Journal Article
Loading…
Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
Schwedt, Todd J., Myers Oakes, Tina M., Martinez, James M., Vargas, Bert B., Pandey, Hitendra, Pearlman, Eric M., Richardson, Diane R., Varnado, Oralee J., Cobas Meyer, Michael, Goadsby, Peter J.
Published in Neurology and therapy (01.02.2024)
Published in Neurology and therapy (01.02.2024)
Get full text
Journal Article
Loading…
Factors and Reasons Associated with Hesitating to Seek Care for Migraine: Results of the OVERCOME (US) Study
Shapiro, Robert E., Muenzel, Eva Jolanda, Nicholson, Robert A., Zagar, Anthony J., L. Reed, Michael, Buse, Dawn C., Hutchinson, Susan, Ashina, Sait, Pearlman, Eric M., Lipton, Richard B.
Published in Neurology and therapy (01.02.2025)
Published in Neurology and therapy (01.02.2025)
Get full text
Journal Article
Loading…
A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN
Lipton, Richard B., Baygani, Simin K., Tepper, Stewart J., Krege, John H., Vasudeva, Raghavendra, Pearlman, Eric M., Hauck, Paula M., Loo, Li Shen
Published in Journal of headache and pain (01.12.2021)
Published in Journal of headache and pain (01.12.2021)
Get full text
Journal Article
Loading…
Topiramate for Migraine Prevention in Children: A Randomized, Double-Blind, Placebo-Controlled Trial
Winner, Paul, Pearlman, Eric M., Linder, Stephen L., Jordan, Donna M., Fisher, Alan C., Hulihan, Joseph
Published in Headache (01.11.2005)
Published in Headache (01.11.2005)
Get full text
Journal Article
Loading…
Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study
Lipton, Richard B., Nicholson, Robert A., Reed, Michael L., Araujo, Andre B., Jaffe, Dena H., Faries, Douglas E., Buse, Dawn C., Shapiro, Robert E., Ashina, Sait, Cambron‐Mellott, M. Janelle, Rowland, John C., Pearlman, Eric M.
Published in Headache (01.02.2022)
Published in Headache (01.02.2022)
Get full text
Journal Article
Loading…
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls
Pearlman, Eric M., Wilbraham, Darren, Dennehy, Ellen B., Berg, Paul H., Tsai, Max, Doty, Erin G., Kay, Gary G.
Published in Human psychopharmacology (01.09.2020)
Published in Human psychopharmacology (01.09.2020)
Get full text
Journal Article
Loading…
Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P-Glycoprotein and Breast Cancer Resistance Protein Substrates
Luffer-Atlas, Debra, Wilbraham, Darren, Posada, Maria M, Landry, John, Tsai, Max, Pearlman, Eric M
Published in Journal of clinical pharmacology (01.01.2024)
Published in Journal of clinical pharmacology (01.01.2024)
Get more information
Journal Article
Loading…
Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life
Shapiro, Robert E, Nicholson, Robert A, Seng, Elizabeth K, Buse, Dawn C, Reed, Michael L, Zagar, Anthony J, Ashina, Sait, Muenzel, E Jolanda, Hutchinson, Susan, Pearlman, Eric M, Lipton, Richard B
Published in Neurology (13.02.2024)
Published in Neurology (13.02.2024)
Get more information
Journal Article
Loading…
Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies
Smitherman, Todd A., Tietjen, Gretchen E., Schuh, Kory, Skljarevski, Vladimir, Lipsius, Sarah, D’Souza, Deborah N., Pearlman, Eric M.
Published in Headache (01.11.2020)
Published in Headache (01.11.2020)
Get full text
Journal Article
Loading…
Patterns of calcitonin gene-related peptide monoclonal antibody use in people with migraine: Results of the OVERCOME (US) study
Ashina, Sait, Kim, Gilwan, Muenzel, E. Jolanda, Buse, Dawn C., Zagar, Anthony J., Zakharyan, Armen, Shapiro, Robert E., Nicholson, Robert A., Pearlman, Eric M., Lipton, Richard B.
Published in Cephalalgia (01.06.2025)
Published in Cephalalgia (01.06.2025)
Get full text
Journal Article
Loading…
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) study
Ashina, Sait, Muenzel, E. Jolanda, Nicholson, Robert A., Zagar, Anthony J., Buse, Dawn C., Reed, Michael L., Shapiro, Robert E., Hutchinson, Susan, Pearlman, Eric M., Lipton, Richard B.
Published in Headache (01.09.2024)
Published in Headache (01.09.2024)
Get full text
Journal Article
Loading…
Loading…
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure
Ruff, Dustin D, Ford, Janet H, Tockhorn-Heidenreich, Antje, Sexson, Matthew, Govindan, Sriram, Pearlman, Eric M, Wang, Shuu-Jiun, Khan, Arif, Aurora, Sheena K
Published in Cephalalgia (01.07.2019)
Published in Cephalalgia (01.07.2019)
Get full text
Journal Article
Loading…
Loading…
Challenge-mig: a phase 4, randomized, double-blind, double-dummy study comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine
Schwedt, Todd J., Myers Oakes, Tina M., Martinez, James M., Vargas, Bert B., Pandey, Hitendra N., Pearlman, Eric M., Richardson, Diane R., Varnado, Oralee J., Meyer, Michael Cobas, Goadsby, Peter J.
Published in Journal of the neurological sciences (01.12.2023)
Published in Journal of the neurological sciences (01.12.2023)
Get full text
Journal Article
Loading…
Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine
Martinez, James M, Hindiyeh, Nada, Anglin, Greg, Kalidas, Kavita, Hodsdon, Michael E, Kielbasa, William, Moser, Brian A, Pearlman, Eric M, Garces, Sandra
Published in Cephalalgia (01.08.2020)
Published in Cephalalgia (01.08.2020)
Get full text
Journal Article
Loading…
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials
Kuruppu, Dulanji K., North, James M., Kovacik, Amy J., Dong, Yan, Pearlman, Eric M., Hutchinson, Susan L.
Published in Advances in therapy (01.03.2021)
Published in Advances in therapy (01.03.2021)
Get full text
Journal Article
Loading…
Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
Pozo-Rosich, Patricia, Samaan, Karen H., Schwedt, Todd J., Nicholson, Robert A., Rettiganti, Mallikarjuna, Pearlman, Eric M.
Published in Advances in therapy (01.06.2021)
Published in Advances in therapy (01.06.2021)
Get full text
Journal Article